EQT:NYSEEQT Corporation Analysis
Data as of 2026-05-27 - not real-time
$55.65
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
EQT Corp trades at $55.65, just above its 20‑day support of $55.11 and well below the 60‑day resistance of $60.66, placing it in a range where a technical bounce could occur. The 20‑day SMA ($57.44) sits above price while the 200‑day SMA ($56.46) is marginally higher, indicating a short‑term neutral to slightly bearish bias, yet the MACD histogram is positive and the signal line turned bullish, suggesting momentum may be shifting upward. Valuation metrics are compelling: a trailing P/E of 10.6 versus an industry average of 20.6, a price‑to‑book of 1.39, and a DCF‑derived fair value of $133.5 imply roughly 25.8% upside. Fundamentals remain strong with revenue growth of 49.9%, gross margin above 80%, operating cash flow exceeding $6.4 B, and a modest dividend yield of 1.17% supported by a low payout ratio of 12%. However, the balance sheet shows a high debt‑to‑equity ratio of 20.8, though cash flow generation comfortably covers interest obligations. Volatility is elevated at 28% over the past month, but beta is low, indicating limited systematic risk.
Overall, the stock appears materially undervalued with solid cash generation and attractive dividend sustainability, while technical indicators hint at a potential near‑term recovery. The combination of strong margins, robust free cash flow, and a low cost basis supports a bullish outlook, though investors should monitor debt levels and sector‑specific regulatory headwinds. The current market sentiment, reflected by an “Extreme Greed” fear‑greed index, further underscores the attractiveness of entering at these levels.
Overall, the stock appears materially undervalued with solid cash generation and attractive dividend sustainability, while technical indicators hint at a potential near‑term recovery. The combination of strong margins, robust free cash flow, and a low cost basis supports a bullish outlook, though investors should monitor debt levels and sector‑specific regulatory headwinds. The current market sentiment, reflected by an “Extreme Greed” fear‑greed index, further underscores the attractiveness of entering at these levels.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near support with bullish MACD crossover
- Low beta and modest volatility relative to sector
- Undervalued relative to peers (P/E 10.6 vs 20.6 industry)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high operating margins
- Sustainable dividend with low payout ratio
- DCF fair value indicating ~25% upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust free cash flow supporting debt repayment
- Long‑term undervaluation and favorable industry dynamics
- Strategic positioning in the Appalachian natural‑gas basin
Key Metrics & Analysis
Financial Health
Revenue Growth49.90%
Profit Margin35.07%
P/E Ratio10.6
ROE13.40%
ROA7.73%
Debt/Equity20.82
P/B Ratio1.4
Op. Cash Flow$6.4B
Free Cash Flow$2.5B
Industry P/E20.6
Technical Analysis
TrendNeutral
RSI40.2
Support$55.11
Resistance$60.66
MA 20$57.44
MA 50$59.68
MA 200$56.46
MACDBullish
VolumeDecreasing
Fear & Greed Index91.21
Valuation
Fair Value$133.51
Target Price$70.00
Upside/Downside25.79%
GradeUndervalued
TypeGrowth
Dividend Yield1.17%
Risk Assessment
Beta0.17
Volatility27.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.